Search

Your search keyword '"Cutuli, B"' showing total 436 results
Start Over Author "Cutuli, B"
436 results on '"Cutuli, B"'

1. Radiotherapy of breast cancer

Author

Hennequin, C., Belkacémi, Y., Bourgier, C., Cowen, D., Cutuli, B., Fourquet, A., Hannoun-Lévi, J.-M., Pasquier, D., Racadot, S., and Rivera, S.

Published
2022
Full Text
View/download PDF

4. Radiothérapie du cancer du sein

Author

Hennequin, C., Barillot, I., Azria, D., Belkacémi, Y., Bollet, M., Chauvet, B., Cowen, D., Cutuli, B., Fourquet, A., Hannoun-Lévi, J.M., Leblanc, M., and Mahé, M.A.

Published
2016
Full Text
View/download PDF

8. Male breast cancer

Author

Cutuli, B., Belkacémi, Yazid, editor, Mirimanoff, René-Olivier, editor, and Ozsahin, Mahmut, editor

Published
2010
Full Text
View/download PDF

20. Quality indicators in breast cancer care

Author

Rosselli Del Turco, M., Ponti, A., Bick, U., Biganzoli, L., Cserni, G., Cutuli, B., Decker, T., Dietel, M., Gentilini, O., Kuehn, T., Mano, M.P., Mantellini, P., Marotti, L., Poortmans, P., Rank, F., Roe, H., Scaffidi, E., van der Hage, J.A., Viale, G., Wells, C., Welnicka-Jaskiewicz, M., Wengstöm, Y., and Cataliotti, L.

Published
2010
Full Text
View/download PDF

21. Radiotherapy of breast cancer

Author

Hennequin, C., primary, Belkacémi, Y., additional, Bourgier, C., additional, Cowen, D., additional, Cutuli, B., additional, Fourquet, A., additional, Hannoun-Lévi, J.-M., additional, Pasquier, D., additional, Racadot, S., additional, and Rivera, S., additional

Published
2021
Full Text
View/download PDF

23. Les recommandations nationales françaises de prise en charge du cancer du sein infiltrant: Onze questions cliniques d’actualité sur le bilan initial, la radiothérapie et les traitements systémiques

Author

Giard, S., Cutuli, B., Antoine, M., Barreau, B., Besnard, S., Bonneterre, J., Campone, M., Ceugnard, L., Classe, J. M., Cohen, M., Dohoullou, N., Fourquet, A., Guinebretière, J. M., Hennequin, C., Leblanc-Onfroy, M., Levy, L., Mazeau-Woynar, V., Mouret Reynier, M. A., Rousseau, C., and Verdoni, L.

Published
2013
Full Text
View/download PDF

36. The 2018 assisi think tank meeting on breast cancer: International expert panel white paper

Author

Arenas, M. Selek, U. Kaidar-Person, O. Perrucci, E. Montero Luis, A. Boersma, L. Coles, C. Offersen, B. Meattini, I. Bölükbaşı, Y. Leonardi, M.C. Pfeffer, R. Cutuli, B. Vidali, C. Franco, P. Kouloulias, V. Masiello, V. Rivera, S. Bourgier, C. Ciabattoni, A. Lancellotta, V. Trigo, L. Valentini, V. Poortmans, P. Aristei, C.

Abstract

We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed. © 2020 Elsevier B.V.

Published
2020

37. About the French prohibition of textured breast implants : is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position

Author

Cardoso, M. J., Biganzoli, L., Rubio, I. T., Leidenius, M., Curigliano, G., Cutuli, B., Marotti, L., Kovacs, T., Wyld, L., HUS Comprehensive Cancer Center, II kirurgian klinikka, and Department of Surgery

Subjects
LARGE-CELL LYMPHOMA, 3123 Gynaecology and paediatrics, 3122 Cancers
Abstract

Corrigendum: Volume: 48 Pages: 103-103 DOI: 10.1016/j.breast.2019.10.010 Non

Published
2019

38. The 2018 assisi think tank meeting on breast cancer: International expert panel white paper

Author

Arenas, M., Selek, U., Kaidar-Person, O., Perrucci, E., Montero Luis, A., Boersma, L., Coles, C., Offersen, B., Meattini, I., Bolukbasi, Y., Leonardi, M. C., Pfeffer, R., Cutuli, B., Vidali, Cristiana, Franco, P., Kouloulias, V., Masiello, V., Rivera, S., Bourgier, C., Ciabattoni, Antonella, Lancellotta, V., Trigo, L., Valentini, Vincenzo, Poortmans, P., Aristei, Cynthia, Vidali C., Ciabattoni A., Valentini V. (ORCID:0000-0003-4637-6487), Aristei C., Arenas, M., Selek, U., Kaidar-Person, O., Perrucci, E., Montero Luis, A., Boersma, L., Coles, C., Offersen, B., Meattini, I., Bolukbasi, Y., Leonardi, M. C., Pfeffer, R., Cutuli, B., Vidali, Cristiana, Franco, P., Kouloulias, V., Masiello, V., Rivera, S., Bourgier, C., Ciabattoni, Antonella, Lancellotta, V., Trigo, L., Valentini, Vincenzo, Poortmans, P., Aristei, Cynthia, Vidali C., Ciabattoni A., Valentini V. (ORCID:0000-0003-4637-6487), and Aristei C.

Abstract

We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.

Published
2020

39. The 2018 assisi think tank meeting on breast cancer: International expert panel white paper

Author

Universitat Rovira i Virgili, Arenas M; Selek U; Kaidar-Person O; Perrucci E; Montero Luis A; Boersma L; Coles C; Offersen B; Meattini I; Bölükbaşı Y; Leonardi MC; Pfeffer R; Cutuli B; Vidali C; Franco P; Kouloulias V; Masiello V; Rivera S; Bourgier C; Ciabattoni A; Lancellotta V; Trigo L; Valentini V; Poortmans P; Aristei C, Universitat Rovira i Virgili, and Arenas M; Selek U; Kaidar-Person O; Perrucci E; Montero Luis A; Boersma L; Coles C; Offersen B; Meattini I; Bölükbaşı Y; Leonardi MC; Pfeffer R; Cutuli B; Vidali C; Franco P; Kouloulias V; Masiello V; Rivera S; Bourgier C; Ciabattoni A; Lancellotta V; Trigo L; Valentini V; Poortmans P; Aristei C

Abstract

© 2020 Elsevier B.V. We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.

Published
2020

46. The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice

Author

Montero-Luis, A, Aristei, C, Meattini, I, Arenas, M, Boersma, L, Bourgier, C, Coles, C, Cutuli, Debora, Falcinelli, L, Kaidar-Person, O, Leonardi, M C, Offersen, B, Marazzi, Fabio, Rivera, S, Tagliaferri, Luca, Tombolini, V, Vidali, C, Valentini, Vincenzo, Poortmans, P, Cutuli, B, Marazzi, F, Tagliaferri, L (ORCID:0000-0003-2308-0982), Valentini, V (ORCID:0000-0003-4637-6487), Montero-Luis, A, Aristei, C, Meattini, I, Arenas, M, Boersma, L, Bourgier, C, Coles, C, Cutuli, Debora, Falcinelli, L, Kaidar-Person, O, Leonardi, M C, Offersen, B, Marazzi, Fabio, Rivera, S, Tagliaferri, Luca, Tombolini, V, Vidali, C, Valentini, Vincenzo, Poortmans, P, Cutuli, B, Marazzi, F, Tagliaferri, L (ORCID:0000-0003-2308-0982), and Valentini, V (ORCID:0000-0003-4637-6487)

Abstract

N/A

Published
2019

47. The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice

Author

Universitat Rovira i Virgili, Montero-Luis A; Aristei C; Meattini I; Arenas M; Boersma L; Bourgier C; Coles C; Cutuli B; Falcinelli L; Kaidar-Person O; Leonardi MC; Offersen B; Marazzi F; Rivera S; Tagliaferri L; Tombolini V; Vidali C; Valentini V; Poortmans P, Universitat Rovira i Virgili, and Montero-Luis A; Aristei C; Meattini I; Arenas M; Boersma L; Bourgier C; Coles C; Cutuli B; Falcinelli L; Kaidar-Person O; Leonardi MC; Offersen B; Marazzi F; Rivera S; Tagliaferri L; Tombolini V; Vidali C; Valentini V; Poortmans P

Abstract

© 2019 Elsevier B.V. Background: Risk factors for local recurrence after mastectomy in ductal carcinoma in situ (DCIS) emerged as a grey area during the second “Assisi Think Tank Meeting” (ATTM) on Breast Cancer. Aim: To review practice patterns of post-mastectomy radiation therapy (PMRT) in DCIS, identify risk factors for recurrence and select suitable candidates for PMRT. Methods: A questionnaire concerning DCIS management, focusing on PMRT, was distributed online via SurveyMonkey. Results: 142 responses were received from 15 countries. The majority worked in academic institutions, had 5–20 years work-experience and irradiated <5 DCIS patients/year. PMRT was more given if: surgical margins <1 mm, high-grade, multicentricity, young age, tumour size >5 cm, skin- or nipple- sparing mastectomy. Moderate hypofractionation was the most common schedule, except after immediate breast reconstruction (57% conventional fractionation). Conclusions: The present survey highlighted risk factors for PMRT administration, which should be further evaluated.

Published
2019

50. SFSPM 2018 — Congrès de la Société Française de Sénologie et de Pathologie Mammaire (Avignon, 7-9/11-2018)

Author

Serin, D., primary, Adnot, S., additional, Allioux, C., additional, Alran, S., additional, Bazin, B., additional, Bendiane, M.-K., additional, Bo-Gallon, E., additional, Boinon, D., additional, Bouhnik, A.-D., additional, Bourstyn, E., additional, Charles, C., additional, Clément, A., additional, Coussirou, J., additional, Cutuli, B., additional, Dauchy, S., additional, Debourdeau, P., additional, Degos, L., additional, Duponchel, P., additional, Durand, T., additional, Eisinger, F., additional, Falandry, C., additional, Favier, B., additional, Heudel, P.E., additional, Ledig, C., additional, Lesur, A., additional, Mancini, J., additional, Monet, A., additional, Moretta, J., additional, Neveu, J., additional, Ninot, G., additional, Préau, M., additional, Ravot, C., additional, Rousset-Jablonski, C., additional, Touzani, R., additional, Valéro, M., additional, and Zambrowski, J.-J., additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results